新2正网平台出租www.hg108.vip)是皇冠(正网)接入菜宝钱包的TRC20-USDT支付系统,为皇冠代理提供专业的网上运营管理系统。系统实现注册、充值、提现、客服等全自动化功能。采用的USDT匿名支付、阅后即焚的IM客服系统,让皇冠代理的运营更轻松更安全。

KUALA LUMPUR: UMediC Group Bhd, which is slated for listing on Bursa Malaysia’s ACE Market on July 26, aims to raise RM31.11 million from its initial public offering (IPO).

The distributor and manufacturer of medical consumables products will allocate RM3.5 million from the gross proceeds to construct a new factory, RM6.8 million to set up new marketing and distribution offices in Kuala Lumpur and Johor, RM9 million for repayment of borrowings, and RM8.66 million for working capital.

Executive director and chief executive officer Lim Taw Seong said it is timely for the group to scale up its business to ride on the growth of Malaysia’s medical device industry, which is expected to record a compound annual growth rate of 12.1 per cent, from RM12.11 billion in 2021 to RM21.41 billion in 2026.

He said the growth is expected to be driven mainly by pent-up demand for medical devices from the medical tourism industry as well as existing and new hospitals.

‘’Most importantly, in light of our manufactured medical consumables, we are seeing an increasing awareness of using disposable medical products to reduce the risks of cross-contamination, especially after the pandemic.

‘’Therefore, our management team foresees a huge untapped potential and we are poised to seize these valuable opportunities,’’ he said during the launch of the prospectus for its IPO today.

UMediC produces HydroX Prefilled Humidifier and AirdroX Spacer Anti-Static Valved Inhaler Chamber, which currently contributes 20 per cent to its total revenue.

,

哈希竞彩www.hx198.vip)采用波场区块链高度哈希值作为统计数据,游戏数据开源、公平、无任何作弊可能性,哈希竞彩开放单双哈希、幸运哈希、哈希定位胆、哈希牛牛等游戏。

,

Eighty per cent of revenue is generated from the distribution segment for products including defibrillators, ventilators, ultrasound machines, furniture, and maternal and infant care.

In the near future, the company targets to grow its medical consumables business’ contribution to revenue to 50 per cent by introducing more new products and increase production capacity.

Lim said the construction of a new factory in Batu Kawan with a built-up area of 35,000 square feet would support the upcoming commercialisation of its new products such as sterile water for inhalation, digital oxygen flowmeters, prefilled nebulisers, and humidity sensors.

The new facility will also support the production expansion of its HydroX and AirdroX series.

Legal and corporate adviser Ng Sze Hui said that once completed, the plant would double the company’s production to 600,000 units from 300,000 units monthly, which is expected to be achieved next month.

She said UMediC distributes its products to more than 30 countries.

Meanwhile, UMediC’s IPO comprises a public issue of 97.22 million new shares at 32 sen per share, out of which 18.69 million shares will be made available to the Malaysian public and 13.08 million shares allocated to eligible directors, employees and business associates, which have contributed to the success of the company.

Usdt自动充值接口声明:该文看法仅代表作者自己,与本平台无关。转载请注明:哈希竞彩:ACE Market-bound UMediC aims to raise RM31.11mil from IPO
发布评论

分享到:

新2平台出租:与学生分享个人经历 陈萨愿人人享受音乐
1 条回复
  1. 泰达币交易所官网(www.usdt8.vip)
    泰达币交易所官网(www.usdt8.vip)
    (2022-11-10 00:10:05) 1#

    市场情绪乐观之际,10年期美债收益率下降至4.21%。根据CME美联储观察工具,美联储连续第四次加息75个基点的概率为95%。无意刷到,厉害了

发表评论

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。